Transcripts for the Epstein-Barr virus (EBV)-encoded nuclear antigens are initiated at the alternative promoters Wp, Cp and Qp. Although the host cell-dependent activity of Cp is regulated by DNA methylation, Qp is unmethylated independently of its activity. Because histone modifications affect the chromatin structure, we compared the levels of diacetylated histone H3, tetraacetylated histone H4 and histone H3 dimethylated on lysine 4 (H3K4me2) at Cp and Qp, in well characterized cell lines representing the major EBV latency types. We found an activity-dependent histone code: acetylated histones marked active Cp, whereas active Qp was selectively enriched both in acetylated histones and H3K4me2. We concluded that active (but not silent) Cp and Qp are located to 'acetylation islands' in latent, episomal EBV genomes, similar to the active chromatin domains of the human genome.
Epstein-Barr virus (EBV) is associated with a variety of neoplasms (see Liebowitz, 1998 for review) . Transcripts for the EBV-encoded nuclear antigens (EBNAs) are initiated at alternative promoters (called Wp, Cp and Qp) that are regulated in a cell type-specific manner by epigenetic mechanisms (reviewed by Li & Minarovits, 2003) . There is an inverse correlation between DNA methylation and Cp activity in lymphoid cells (Robertson et al., 1995; Salamon et al., 2001) . In contrast, the regulatory region of Qp is unmethylated in all EBV latency types (I and II: Qp on; III: Qp off) (Tao et al., 1998; Salamon et al., 2001) . Because the episomal copies of EBV DNA are in a chromatin structure (Dyson & Farrell, 1985) , and the structure of histones affects the activity of chromatin, we used chromatin immunoprecipitation (ChIP; Weinmann & Farnham, 2002; Fejer et al., 2003) to detect covalent histone modifications (acetylation and methylation; reviewed by Verdone et al., 2005; Jenuwein & Allis, 2001 ) at Cp and Qp, 3These authors contributed equally to this work. (Gregory et al., 1990) . Mutu-BL-I-Cl-216 maintains the phenotype of BL biopsy cells and expresses EBNA 1 and the small EBV-encoded RNAs, EBER 1 and 2, but EBNA 2-5 and latent membrane proteins (LMPs) cannot be detected in this clone (type I latency, Cp off, Qp on). In contrast, Mutu-BL-III-Cl-99 has a lymphoblastoid phenotype and expresses all six EBNAs, EBER 1 and 2, and LMP 1 and 2 (type III latency, Cp on, Qp off) (Gregory et al., 1990; Altiok et al., 1992; Bakos et al., 2007) . The BL line Rael (latency I) and the lymphoblastoid cell line (LCL) CB-M1-Ral-STO (latency III) also carry the same EBV strain (Ernberg et al., 1989) . Among the Qp-user non-BL cells, the nasopharyngeal carcinoma cell line C666-1 (Cheung et al., 1999) carries an EBV strain different from that carried by BC1, a well characterized primary effusion lymphoma cell line (Szekely et al., 1998) .
Here, we report that active Cp is highly enriched in acetylated histones H3 and H4. Acetylation of histones H3 and H4 at Cp was analysed by ChIP (Weinmann & Farnham, 2002; Fejer et al., 2003) , using antibodies directed to diacetylated histone H3 and tetraacetylated histone H4 (AcH3 and AcH4). DNA from precipitated chromatin was amplified by real-time PCR. A pair-wise comparison of cell lines or clones carrying the same EBV strain but belonging to latency type III (Cp on) or latency type I (Cp off), respectively, showed that the actively used Cp in CB-M1-Ral-STO was 17-fold enriched in AcH3 compared with the silent Cp in Rael (Fig. 1a) , whereas there was a 14-fold enrichment in AcH3 at the active Cp in Mutu-BL-III-Cl-99 compared with the silent Cp in Mutu-BL-I-Cl-216 (Fig. 1a) . The silent C promoters were poor in AcH3 in C666-1 and BC1 cells as well (Fig. 1a) . AcH4 was ninefold and almost 13-fold more abundant at the active Cp in CB-M1-Ral-STO and Mutu-BL-III-Cl-99 compared with the silent Cp in Rael and Mutu-BL-I-Cl-216, respectively, whereas the silent C promoters in C666-1 and BC1 cells were also associated with hypoacetylated histone H4 (Fig. 1b) . In independent experiments, using the methods of semi-quantitative PCR and competitive PCR (Igaz et al., 1998) , we obtained similar results (data not shown). A coordinated acetylation of histones H3 and H4 was observed at active cellular promoters as well (Zhang et al., 2005; Brinkman et al., 2007) . Because densely methylated DNA associates with underacetylated histones in transcriptionally inactive chromatin regions (Jones et al., 1998; Nan et al., 1998; Fuks et al., 2000; Ng et al., 2000) , we found that our results are consistent with the high level of CpG methylation found at inactive, but not active C promoters (Altiok et al., 1992; Robertson et al., 1995; Salamon et al., 2001) . However, there is some variation between our data and the results of another laboratory (Chau & Lieberman, 2004 ). Chau and Lieberman observed only a marginal (1.4-fold) enrichment of AcH3 at the corresponding region of Cp in an LCL (Cp on; carrying unrelated EBV genomes than the BL cell line they studied) than in a BL line (Cp off). The 898 bp fragment they amplified (nt 10504-11402 of the prototype B95-8 EBV genome; P.M. Lieberman, personal communication) is considerably larger than (although covers) the 129 bp region amplified by our primers (covering nt 10981-11110 of the prototype B95-8 EBV genome). Identical results were achieved when analysing AcH4 levels. The differences between the results from the Lieberman laboratory and our laboratory regarding the AcH3 and AcH4 levels observed at Cp may be due to the different cell lines analysed and the different primers used. Treating Mutu-BL-I-Cl-216 and C666-1 cells (Cp off) with trichostatin A (TSA), an inhibitor of histone deacetylases, resulted in an enrichment of AcH4 at Cp (Fig. 1b) . To confirm the functional significance of histone acetylation, we measured the level of Cp-initiated transcripts in cells differing in Cp usage (Fig. 1d ) and in TSA-treated and control Mutu-BL-I-Cl-216 cells (Fig. 1f) . Cp was active only in type III latency, as described previously (Woisetschlaeger et al., 1991; Altiok et al., 1992; reviewed by Györy & Minarovits, 2005) . TSA alone or combined with cycloheximide (CHX) induced Cp-initiated transcription in Mutu-BL-I-Cl-216, although this induced transcription did not reach the level of Cp activity detected in the latency type III Mutu clone (Weinmann & Farnham, 2002) was prepared from the indicated cells and immunoprecipitated with specific antibodies (Upstate) directed to diacetylated histone H3 (a), tetraacetylated histone H4 (b), histone H3 dimethylated at lysine 4 (H3K4me2) (f) or was mock-precipitated with a non-specific antibody (c). Abbreviations: Mutu-I (Mutu-BL-I-Cl-216); Mutu-III (Mutu-BL-III-Cl-99) and CBM1 (CB-M1-Ral-STO). Recovered DNA aliquots were amplified using real-time PCR (LightCycler; Roche) with primers specific for the 59 regulatory region of Cp, corresponding to nt 10981-11005 and 11110-11087 of the B95-8 prototype EBV genome (Baer et al., 1984) . In (b), Mutu-BL-I-Cl-216 (Mutu-I) and C666-1 cells were untreated or treated for 16 h with 600 nM TSA; in (e) TSA treatment of Mutu cells was also combined with 10 mg ml "1 CHX. In (d) and (e), the relative levels of transcripts initiated at Cp were determined with real-time RT-PCR (LightCycler; Roche). The RT reaction was initiated using a primer corresponding to nt 11657-11636 of the B95-8 prototype EBV genome (Baer et al., 1984) and oligonucleotide 59-TGTAACGCAACTAAGTCATAG-39 complementary to the human b-actin mRNA. For the PCR, we used primers corresponding to nt 11333-11361 and 11642-11626 of the prototype B95-8 EBV genome (Baer et al., 1984) , and oligonucleotides 59-GGCGGCACCACCATGTACCCT-39 and 59-AGGGGCCGGACTCGTCATACT-39 amplifying a region of the human b-actin cDNA, respectively. The relative level of Cp-specific RNA expression was calculated after correcting for endogenous b-actin RNA expression levels. (Fig. 1e) . Because histone acetylation is associated with a chromatin structure permissive for transcription (Verdone et al., 2005) , these data fit well with the enrichment of AcH4 at Cp in TSA-treated Mutu-BL-ICl-216 cells (Fig. 1b) . Enrichment in histone H3 methylated at the lysine 4 (K4) residue (H3mK4) correlates with the activity of certain promoters (Jenuwein & Allis, 2001 ). Therefore, we analysed the level of H3K4me2 at active and silent C promoters. Surprisingly, we detected comparable H3K4me2 levels at Cp in both Mutu clones, although they differ in Cp usage (Fig. 1f) . In contrast, H3K4me2 was approximately three times less abundant in Rael (Cp off) than in CB-M1-Ral-STO (Cp on). The lowest H3K4me2 signal was observed in C666-1 and BC1 (Cp off). These data show that even a high level of H3K4me2 is insufficient, by itself, to switch on Cp in Mutu-BL-I-Cl-216 cells, and are in contrast with the conclusion of Chau and Lieberman, who suggested that Cp activity is connected to enrichment in H3K4me2 (Chau & Lieberman, 2004) . We suggest that H3K4me2 may contribute to the maintenance of a 'poised' chromatin state at the silent Cp in Mutu-BL-I-Cl-216, similar to inactive promoters at the b-globin locus (Schneider et al., 2004) . We also report here that active Qp is enriched in AcH3, AcH4 and H3K4me2. We found elevated levels of AcH3, AcH4 and H3K4me2 at the active Q promoters (Rael, Mutu-BL-I-Cl-216 and C666-1) compared with the silent ones (CB-M1-Ral-STO and Mutu-BL-III-Cl-99) (Fig.  2) . Among the cells actively using Qp the highest levels of chromatin-opening histone modifications were observed in C666-1 cells (Fig. 2) . This corresponds to the high level of Qp-initiated transcripts detected in these cells (Bakos et al., 2007) .
IP
In summary, our data indicate that a latency type-specific, activity-dependent histone-code marks Cp and Qp in the major EBV-carrying cell types. We detected highly elevated levels of AcH3 and AcH4 at the active, but not at the silent C promoters. These data are consistent with the high level of DNA-methylation described at the regulatory region of silent C promoters (Altiok et al., 1992; Robertson et al., 1995; Salamon et al., 2001; Bakos et al., 2007) because methylated CpG-rich regions are known to be associated with histone deacetylases (Jones et al., 1998; Nan et al., 1998; Fuks et al., 2000; Ng et al., 2000) . Our data show that the active (but not the silent) C promoters in latent EBV genomes are localized to a region rich in AcH3 and AcH4, which is similar to the acetylation islands characteristic to the active chromatin domains in human T cells, as described by Roh et al. (2005) . Our data also fit well with our observation that enhanced levels of acetylated histones H3 and H4 mark the upregulated LMP2A promoter of EBV in lymphoid cells (Gerle et al., 2007) . Using an LCL conditional for EBNA 2, Alazard et al. (2003) observed that in the presence of b-oestradiol binding of an EBNA 2/ oestrogen receptor fusion protein to Cp results in a significant local increase in histone H4 acetylation, and a slight increase of histone H3 acetylation. In contrast, binding to another EBNA 2 activated regulatory region, the promoter of the LMP1 gene, correlated with an increase in AcH3, but not AcH4 (Alazard et al., 2003) . These data fit well with our observation that active Cp is located on an acetylated island, although a fusion protein may induce somewhat different local histone modifications than native EBNA 2. The data of Alazard et al. (2003) are also in agreement with our observation that in Mutu-BL-I-Cl-216 cells inhibition of histone deacetylase by TSA upregulates Cp activity (Fig. 1e) and results in an increased AcH4 level at Cp (Fig. 1b) . We found that in clones of the BL line Mutu, H3K4me2 may be enriched at Cp independent of promoter activity (Fig. 1f) . However, a significant enrichment of H3K4me2 at Cp in the Mutu-I cells was not observed in another laboratory (Chau & Lieberman, 2004; Day et al., 2007) . This discrepancy may be due to the different passage history of the cells used. While Cp activity is regulated by both CpG methylation (Altiok et al., 1992; Minarovits et al., 1994; Robertson et al., 1995; Salamon et al., 2001; Bakos et al., 2007) and histone modifications (this study), Qp is unmethylated independently of its activity (Tao et al., 1998; Salamon et al., 2001) . We observed that similar to active Cp, active Q promoters in lymphoid and epithelial cells are also located on an acetylation island enriched in AcH3 and AcH4. There is variation between our data and that of Day et al. (2007) , who did not detect an enrichment in AcH3 at the active Qp Fig. 2 . Histone modifications at Qp and epigenetic marks in latency type I and III Epstein-Barr virus genomes. The levels of (AcH3, AcH4 and H3K4me2 associated with Qp were measured in ChIP samples prepared from the indicated cells using antibodies (Upstate) directed against diacetylated histone H3 (a), tetraacetylated histone H4 (b) or H3 dimethylated at lysine 4 (H3K4me2) (c). Samples mock-precipitated with a non-specific antibody were used as controls (d). Recovered DNA aliquots were amplified using real-time PCR (as in Fig. 1 ) with primers located upstream from and overlapping the transcription initiation site of Qp, corresponding to nt 62294-62317 and 62429-62406 of the prototype B95-8 EBV genome (Baer et al., 1984) , respectively. The epigenetic marks of a latent EBV episome in type I latency are shown in (e) and in type III latency in (f). The circular episomal genome is shown with the latent viral promoters (arrows) and their regulatory regions, including the long-range enhancer/latent origin of DNA replication oriP (not to scale). The concept of EBV locus control region was described by Niller et al. (2004) . TR, Terminal repeats; LRS, LMP1 regulatory sequences; Rep*, an element (overlapping with the promoter vIL-10) that can partially replace the function of oriP. +, High level of regional CpG methylation; ", unmethylated or hypomethylated CpG dinucleotides (the EBV epigenotypes are reviewed by Minarovits, 2006) . X designates a silent promoter. 'Acetylation islands', enriched in diacetylated histone H3 and tetraacetylated histone H4, are indicated by open boxes at latent promoters (based on Gerle et al., 2007 and the results of this paper).
in Mutu-I cells. This may be due to differences in the cells and methods used in the two laboratories. In addition to enrichment in AcH3 and AcH4, we also found that active Q promoters are selectively marked by high levels of H3K4me2. Day et al. (2007) also detected elevated H3K4me2 at Qp in the Mutu-I cells they studied, as well as in Raji cells (a BL line not known to use Qp). We suggest that Qp usage is regulated, in addition to a putative repressor protein (Salamon et al., 2001) , by regional histone modifications. To our knowledge this is the first study connecting upregulation of Cp and Qp activity with a local, coordinated increase in the acetylation of histones H3 and H4.
